# Oxcarbazepine

## Trileptal 60mg/mL, 100mL oral suspension

##### 臨採

| TAH Drug Code      | [LTRIL](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=LTRIL)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Monotherapy & adjuvant treatment of partial seizures in adult. Adjuvant treatment of partial seizure in children over 1 month old.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Dosing             | Adult & elderly Mono or combine therapy: 600 mg/day (8-10 mg/kg/day) in 2 divided doses. Maintenance: 600 mg/day & 2400 mg/day. May be increased by a maximum of 600 mg/day increments at approximate weekly intervals. Maximum: 2400 mg/day over 48 hr in a controlled hospital setting. -Childn Mono-& adjunctive therapy: 8-10 mg/kg/day in 2 divided doses. Maintenance: 31-60 mg/kg/day for adjunctive therapy. May be increased by a maximum of 10 mg/kg/day increments at approximate weekly intervals from starting dose to maximum daily dose of 60 mg/kg/day. -Renal impairment CrCl <30 mL/min Start at 300 mg/day & increase slowly to achieve the desired clinical response. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Contraindications  | Hypersensitivity to oxcarbazepine, any component of the product, or eslicarbazepine acetate.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| Adverse Effects    | Somnolence, headache, dizziness; diplopia; vomiting, nausea; fatigue. Hyponatremia; agitation, affect lability, confusional state, depression, apathy; ataxia, tremor, nystagmus, disturbance in attention, amnesia; blurred vision, visual disturbance; vertigo; diarrhea, abdominal pain, constipation; rash, alopecia, acne; asthenia. Children 1 mth to <4 yr: Ataxia, irritability, vomiting, lethargy, fatigue, nystagmus, tremor, decreased appetite & increased blood uric acid.                                                                                                                                                                                                  |
| Pregnancy          | No (Limited) Human Data – Animal Data Suggest Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| More Info          | [UpToDate](https://www.uptodate.com/contents/oxcarbazepine-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |

## Trileptal 300mg

| TAH Drug Code      | [OTRIL](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OTRIL)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Monotherapy & adjuvant treatment of partial seizures in adult. Adjuvant treatment of partial seizure in children over 1 month old.                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Dosing             | Adult 600-2400 mg/day in 2 divided doses. Children Initially 8-10 mg/kg/day in 2 divided doses. Dosage may be increased according to response in steps of up to 10 mg/kg daily at weekly intervals. maximum: 46 mg/kg daily in divided doses.                                                                                                                                                                                                                                                                                                                               |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Contraindications  | Hypersensitivity to oxcarbazepine, any component of the product, or eslicarbazepine acetate.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Adverse Effects    | Frequent: Fatigue, dizziness, headache, somnolence, nausea, vomiting, diplopia. Common: Asthenia, agitation, amnesia, apathy, ataxia, impaired concentration, confusion, depression, emotional lability, nystagmus, tremor, constipation, diarrhea, abdominal pain, asymptomatic hyponatremia, acne, alopecia, rash, vertigo, vision disorders. Uncommon: Leucopenia, increase in liver enzyme, urticaria. Very rare: Angioedema, multi-organ hypersensitivity disorders, arrhythmia, thrombocytopenia, hepatitis, symptomatic hyponatremia, Stevens-Johnson syndrome, SLE. |
| Pregnancy          | No (Limited) Human Data – Animal Data Suggest Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| More Info          | [UpToDate](https://www.uptodate.com/contents/oxcarbazepine-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |

